2013 - Fellow, National Academy of Inventors
Lisa A. Cannon-Albright mostly deals with Genetics, Internal medicine, Oncology, Genome-wide association study and Locus. Her studies in Cancer, Breast cancer, Risk factor and Relative risk are all subfields of Internal medicine research. The concepts of her Oncology study are interwoven with issues in Genetic model, Survival analysis and Age of onset.
Lisa A. Cannon-Albright has included themes like SNP, PROSTATE CANCER SUSCEPTIBILITY, Case-control study and Genetic association in her Genome-wide association study study. Her Locus research is multidisciplinary, incorporating elements of Microsatellite and Melanoma. Her study looks at the relationship between Genotype and topics such as Prostate cancer, which overlap with Prostate.
The scientist’s investigation covers issues in Internal medicine, Genetics, Oncology, Prostate cancer and Cancer. Gene, Single-nucleotide polymorphism, Genome-wide association study, Pedigree chart and Genetic linkage are the subjects of her Genetics studies. Her Gene research incorporates elements of Cancer research and Melanoma.
Her Oncology research incorporates themes from Survival analysis, Ovarian cancer, Epidemiology and Gynecology. The Prostate cancer study combines topics in areas such as Prostate, Bioinformatics, Germline, Genotype and Hazard ratio. Her Cancer research incorporates themes from Disease and Pathology.
Her primary areas of investigation include Internal medicine, Prostate cancer, Genetics, Cancer and Gene. Her Internal medicine research is multidisciplinary, incorporating elements of Proband and Oncology. Her research integrates issues of Stage, Breast cancer, Genetic predisposition and Genotype in her study of Oncology.
Lisa A. Cannon-Albright interconnects SNP, Cancer research, Genome-wide association study, Percentile and Hazard ratio in the investigation of issues within Prostate cancer. Her Cancer research includes elements of Young adult, Pediatrics and Cohort study. Her research investigates the connection with Gene and areas like Disease which intersect with concerns in Odds ratio, Pulmonary embolism and ICD-10.
Her primary areas of study are Prostate cancer, Internal medicine, Genetics, Cancer and Gene. Her Prostate cancer study combines topics from a wide range of disciplines, such as Sample size determination, Genome-wide association study, Oncology, Hazard ratio and Breast cancer. Her Breast cancer study which covers Imputation that intersects with Genetic association.
Her Internal medicine study incorporates themes from Genetic model, ICD-10 and Mutation. Lisa A. Cannon-Albright frequently studies issues relating to CADASIL and Genetics. Her Cancer research integrates issues from Health equity, Multivariate analysis and Case-control study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
Yoshio Miki;Jeff Swensen;Donna Shattuck-Eidens;P. Andrew Futreal.
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
D Ford;D F Easton;M Stratton;S Narod.
American Journal of Human Genetics (1998)
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
Richard Wooster;Susan L. Neuhausen;Jonathan Mangion;Yvette Quirk.
Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.
David. E. Goldgar;Douglas. F. Easton;Lisa. A. Cannon-Albright;Mark H. Skolnick.
Journal of the National Cancer Institute (1994)
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.
S.V. Tavtigian;J. Simard;J. Rommens;F. Couch.
Nature Genetics (1996)
Analysis of the p16 gene (CDKN2) as a candidate· for the chromosome 9p melanoma susceptibility locus
A. Kamb;D. Shattuck-Eidens;R. Eeles;R. Eeles;Qingyun Liu.
Nature Genetics (1994)
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants
Nilah M M. Ioannidis;Joseph H H. Rothstein;Joseph H H. Rothstein;Vikas Pejaver;Sumit Middha.
American Journal of Human Genetics (2016)
Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers
Timothy R. Rebbeck;Albert M. Levin;Andrea Eisen;Carrie Snyder.
Journal of the National Cancer Institute (1999)
Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22.
Lisa A. Cannon-Albright;David E. Goldgar;Laurence J. Meyer;Cathryn M. Lewis.
A candidate prostate cancer susceptibility gene at chromosome 17p.
Sean V. Tavtigian;Jacques Simard;David H F Teng;Vicki Abtin.
Nature Genetics (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: